What's Happening?
CF, a consultancy firm specializing in the health and healthcare sector, has appointed Ioannis Katsoulis as the director of life sciences. Katsoulis brings over 12 years of experience in global market
access, pricing, and health policy research. His role will focus on expanding CF's market access capabilities and delivering data-driven solutions to improve patient outcomes. Katsoulis has a strong track record in strategic insights for pharmaceutical and biotech companies, having worked with cross-functional teams to optimize therapy value propositions. His previous roles include Associate Principal at IQVIA and positions at Evidera and ICON, where he engaged in health technology assessment and market access strategies.
Why It's Important?
The appointment of Ioannis Katsoulis is significant for CF as it underscores the firm's commitment to enhancing its life sciences expertise. Katsoulis's experience in leveraging real-world evidence for healthcare decision-making aligns with CF's mission to drive impactful outcomes in the healthcare sector. His expertise is expected to open new opportunities globally, particularly in major markets like the EU, UK, US, China, and Japan. This move is likely to strengthen CF's position in the competitive consultancy landscape, offering clients enhanced capabilities in market access and health technology assessments.
What's Next?
With Katsoulis on board, CF is poised to deepen its engagement with global pharmaceutical and biotech companies. The firm aims to leverage Katsoulis's expertise to expand its market access capabilities and deliver transformative outcomes for clients. This strategic appointment is expected to enhance CF's ability to provide innovative solutions and improve healthcare systems worldwide. The firm will likely focus on building a team that can deliver on its vision of driving meaningful impact across the healthcare sector.
